June 16, 2008 - Mindray Medical International Ltd. received FDA 510(k) clearance for its DC-3 color ultrasound system. ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbableĀ stents, and renal stents.Ā
June 12, 2008 - Sorin Group closed the sale of its peripheral stent business to Datascope Corp., divesting its noncore ...
June 11, 2008
June 12, 2008 ā The registry arm of a clinical study to assess the safety and effectiveness of Cook Medicalās ...
June 11, 2008Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023June 9, 2008 - Atrium Medical has begun enrollment of the first patients for their CONFIRM 1, First-in-Man (FIM) drug ...
June 08, 2008June 3, 2008 - The CE certified Over and Under Pericardium Covered Stent (PCS) commercial implantation and first ...
June 02, 2008June 2, 2008 - Abbott has submitted an application for Seizo Hanbai Shonin (Marketing Authorization License) to Japan's ...
June 01, 2008The vProtect Luminal Shield is a self-expanding intracoronary prosthesis designed to limit arterial injury that ...
May 29, 2008May 30, 2008 - Three patients with established cardiac ischemia recently became the first recipients of the ...
May 29, 2008May 27, 2008 - Angiomax (bivalirudin) significantly improved net clinical adverse events by 24 percent as well as ...
May 26, 2008May 22, 2008 - MIV Therapeutics Inc. has enrolled the first patients in the registration trial of its VESTAsync polymer ...
May 21, 2008May 20, 2008 - There were no device-related events at 30 days follow-up of the first 13 patients in the OPEN I clinical ...
May 19, 2008
Feature | Ellen W. Rothschild, RN, MS
As new drug-eluting stents (DES) receive premarket approval (PMA) from the FDA, despite an abrupt downturn in the market ...
May 13, 2008
Medtronicās Endeavor Zotarolimus-Eluting Coronary Stent System is engineered for the treatment of coronary artery ...
May 12, 2008May 1, 2008 - The clinical impact of the first-ever prohealing stent, OrbusNeich's Genous Bio-engineered R stent, is ...
April 30, 2008April 25, 2008 - An everolimus-eluting stent compared with a paclitaxel-eluting stent resulted in reduced angiographic ...
April 24, 2008Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now